TNSN06113A1 - Antagonists of the bradykinin b1 receptor - Google Patents
Antagonists of the bradykinin b1 receptorInfo
- Publication number
- TNSN06113A1 TNSN06113A1 TNP2006000113A TNSN06113A TNSN06113A1 TN SN06113 A1 TNSN06113 A1 TN SN06113A1 TN P2006000113 A TNP2006000113 A TN P2006000113A TN SN06113 A TNSN06113 A TN SN06113A TN SN06113 A1 TNSN06113 A1 TN SN06113A1
- Authority
- TN
- Tunisia
- Prior art keywords
- present
- bradykinin
- antagonists
- receptor
- peptides
- Prior art date
Links
- 102000017916 BDKRB1 Human genes 0.000 title 1
- 108010044231 Bradykinin B1 Receptor Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 231100000676 disease causative agent Toxicity 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to certain biologically active peptides and conjugated peptides which can be used as therapeutics or prophylactics against diseases or conditions linked to B1 as the causative agent. In a preferred embodiment of the invention biologically active PEG-conjugated peptides are provided. In one aspect of the present invention, pharmacologically active PEG-conjugated peptides of the present invention are useful to treat inflammation or pain.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51391303P | 2003-10-22 | 2003-10-22 | |
| PCT/US2004/034976 WO2005042027A2 (en) | 2003-10-22 | 2004-10-22 | Antagonists of the bradykinin b1 receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN06113A1 true TNSN06113A1 (en) | 2007-11-15 |
Family
ID=37610132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2006000113A TNSN06113A1 (en) | 2003-10-22 | 2006-04-20 | Antagonists of the bradykinin b1 receptor |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1897976A (en) |
| TN (1) | TNSN06113A1 (en) |
| ZA (1) | ZA200603912B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8592426B2 (en) * | 2011-01-24 | 2013-11-26 | Hoffmann—La Roche Inc. | Aryl-benzocycloalkyl amide derivatives |
| CN105085633B (en) * | 2014-05-12 | 2019-10-08 | 复旦大学 | Active polypeptide and application thereof is combined with bradykinin receptor |
| US11401303B2 (en) * | 2020-06-15 | 2022-08-02 | Taian City Qihang Biotechnology Co. | Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof |
-
2004
- 2004-10-22 CN CNA2004800381506A patent/CN1897976A/en active Pending
- 2004-10-22 ZA ZA200603912A patent/ZA200603912B/en unknown
-
2006
- 2006-04-20 TN TNP2006000113A patent/TNSN06113A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1897976A (en) | 2007-01-17 |
| ZA200603912B (en) | 2007-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG149872A1 (en) | Antagonists of the bradykinin b1 receptor | |
| BR0308090A (en) | cytotoxic or therapeutic agent conjugates and biologically active peptides | |
| TW200605870A (en) | Topical methadone compositions and methods for using the same | |
| WO2005107726A3 (en) | Method for the treatment of back pain | |
| CY1114448T1 (en) | PHARMACEUTICAL COMPOSITIONS AND USE OF THESE IN WOMEN'S SEXUAL INTERFERENCE | |
| WO2002099388A3 (en) | Benzodiazepine bradykinin antagonists | |
| GB2431346C (en) | A combination composition comprising paracetamol and ibuprofen | |
| ATE423114T1 (en) | AMINOCYCLOPROPANE CARBONIC ACID AMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS | |
| TNSN06113A1 (en) | Antagonists of the bradykinin b1 receptor | |
| WO2005082070A3 (en) | Compositions and methods for the systemic treatment of arthritis | |
| IL166596A0 (en) | Salt of morphine-6-glucoronide | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
| WO2005087792A3 (en) | Materials and methods relating to the treatment of glioblastomas | |
| EP1741430A4 (en) | REMEDY FOR PSYCHO NEUROSIS DISEASES | |
| WO2004012732A3 (en) | Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy | |
| GB0304549D0 (en) | Biologically and therapeutically active agents against HIV-1 | |
| MX2009001631A (en) | Pharmaceutical formulation for the treatment of complaints. | |
| GB0410138D0 (en) | Biologically and therapeutically active agents against HIV-1 | |
| GB0218483D0 (en) | Biologically and therapeutically active agents against HIV-1 | |
| HK1073999A (en) | Conjugates of therapeutic or cytotoxic agents and biologically active peptides | |
| GB0305644D0 (en) | Biologically and therapeutically active agents | |
| GB0306345D0 (en) | Biologically and therapeutically active agents | |
| AU2004904557A0 (en) | Novel biomimetic peptide complex for the reduction of pain and injury in animals | |
| GB0411432D0 (en) | Biologically and therapeutically active agents | |
| AR046917A1 (en) | A COMPOSITION THAT INCLUDES ANTAGONISTS OF THE BRADICININE B1 RECEIVER |